0001520138-23-000053.txt : 20230118 0001520138-23-000053.hdr.sgml : 20230118 20230118162152 ACCESSION NUMBER: 0001520138-23-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221123 FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEIZER TERREN S CENTRAL INDEX KEY: 0000904534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39015 FILM NUMBER: 23534680 MAIL ADDRESS: STREET 1: 11111 SANTA MONICABLVD STE.500 CITY: LOS ANGELES STATE: CA ZIP: 90025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 4 1 ownership.xml X0306 4 2022-11-23 0 0001580149 BIOVIE INC. BIVI 0000904534 PEIZER TERREN S C/O ACUITAS GROUP HOLDINGS, LLC 2001 WILSHIRE BLVD #330 LOS ANGELES CA 90403 1 0 1 0 STOCK OPTION (RIGHT TO BUY) 6.12 2022-11-23 4 A 0 65000 0 A 2032-11-23 COMMON STOCK 65000 65000 D Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. The options vest in four equal installments over a one-year period ending November 9, 2023. /S/ TERREN PEIZER 2023-01-13